Business · 31/12/2003

FDA Amends Final Monograph for Over-the-Counter Pediculicide Drug Products

The Food and Drug Administration (FDA) is issuing a final rule amending the final monograph for over-the-counter pediculicide drug products to revise labeling for the statement of identity, warnings, directions, and other required statements. The rule aims to improve the safety and efficacy of these products, which are used to treat head, pubic (crab), and body lice.